Literature DB >> 3661810

Surgical management of Achilles tendinitis.

A A Schepsis1, R E Leach.   

Abstract

Inflammation of the Achilles tendon and its contiguous structures is one of the most common overuse problems seen in runners. There are actually several etiologies. Involvement of the tendon itself is secondary to areas of mucinoid or fibrotic degeneration, or may be a result of a partial rupture. The sheath (or mesotenon) may also become chronically inflammed. Retrocalcaneal bursitis seems to be a separate entity with hypertrophy and fibrosis of the bursa usually occurring in conjunction with a prominent posterior superior angle of the os calcis. The vast majority of patients can be successfully treated nonoperatively; however, there is a group of patients who are refractory to nonoperative management who would like to continue running, particularly if they are competitive. A retrospective review of 45 surgical cases in 37 patients was performed. All but two of these patients were competitive long-distance runners. There were 24 cases of Achilles tendinitis and/or tenosynovitis, 14 cases with retrocalcaneal bursitis, and 7 with a combination of both. Mean followup was 3 years (range, 1 1/2 to 8 years). Overall there were 87% satisfactory results. Ninety-two percent of the patients with involvement with the tendon and/or sheath had a satisfactory outcome as compared with 71% of patients with retrocalcaneal bursitis. Passive dorsiflexion in the 29 unilateral cases improved from a mean of 17 degrees preoperatively to a mean of 25 degrees postoperatively. We feel that surgery offers a solution for highly motivated runners with chronic posterior heel pain who would like to continue running when conservative measures have failed.

Entities:  

Mesh:

Year:  1987        PMID: 3661810     DOI: 10.1177/036354658701500403

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  25 in total

1.  Endoscopic calcaneoplasty--rationale, surgical technique, and early results: a preliminary report.

Authors:  J Jerosch; N M Nasef
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2003-04-23       Impact factor: 4.342

Review 2.  Achilles tendinopathy: some aspects of basic science and clinical management.

Authors:  D Kader; A Saxena; T Movin; N Maffulli
Journal:  Br J Sports Med       Date:  2002-08       Impact factor: 13.800

3.  Chronic Achilles tendinosis: recommendations for treatment and prevention.

Authors:  H Alfredson; R Lorentzon
Journal:  Sports Med       Date:  2000-02       Impact factor: 11.136

4.  Vascular alterations in the rabbit patellar tendon after surgical incision.

Authors:  M R Doschak; J R Matyas; D A Hart; R C Bray
Journal:  J Anat       Date:  2001-05       Impact factor: 2.610

5.  The Achilles tendon insertion is crescent-shaped: an in vitro anatomic investigation.

Authors:  Heinz Lohrer; Sabine Arentz; Tanja Nauck; Nadja V Dorn-Lange; Moritz A Konerding
Journal:  Clin Orthop Relat Res       Date:  2008-05-28       Impact factor: 4.176

Review 6.  Common injuries in runners. Diagnosis, rehabilitation and prevention.

Authors:  M Fredericson
Journal:  Sports Med       Date:  1996-01       Impact factor: 11.136

7.  Achilles tendon lesions in sport.

Authors:  J G Williams
Journal:  Sports Med       Date:  1993-09       Impact factor: 11.136

Review 8.  Achilles tendon injuries in athletes.

Authors:  M Kvist
Journal:  Sports Med       Date:  1994-09       Impact factor: 11.136

9.  Endoscopic treatment of chronic mid-portion Achilles tendinopathy: novel technique with short-term results.

Authors:  Hajo Thermann; Ioannis S Benetos; Christina Panelli; Iosif Gavriilidis; Sven Feil
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-03-14       Impact factor: 4.342

10.  Surgical treatment for chronic Achilles tendinopathy: a prospective seven month follow up study.

Authors:  Mika Paavola; P Kannus; S Orava; M Pasanen; M Järvinen
Journal:  Br J Sports Med       Date:  2002-06       Impact factor: 13.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.